New insights into the treatment of hypertension

被引:0
作者
Tomlinson, B [1 ]
机构
[1] CHINESE UNIV HONG KONG, HONG KONG, HONG KONG
关键词
antihypertensive drugs; calcium antagonists; guidelines; hypertension;
D O I
10.1111/j.1440-1681.1997.tb02733.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. The choice of initial pharmacological therapy is one area where the different hypertension management guidelines vary in recommending either the use of diuretics and beta-blockers as preferred drugs or choosing from any of the five major classes of antihypertensives. 2. Improvement in cardiovascular morbidity and mortality mag have been shown most conclusively with diuretics and beta-blockers, but the effects on coronary events with these drugs were less than predicted and the other agents have a number of theoretical advantages. 3. Recent worries regarding time possible adverse effects of calcium antagonists have led to a reappraisal of the risks and benefits of these drugs and antihypertensives in general. 4. Many patients, particularly the elderly, have other conditions that influence the choice of first-line therapy and ethnic variations in the effects of hypertension or the efficacy or side effects of drugs should also be taken into account. 5. There is considerable heterogeneity within the major categories of antihypertensive drugs, so it is important to distinguish the different subgroups, dosages and formulations that may be used.
引用
收藏
页码:978 / 981
页数:4
相关论文
共 50 条
  • [21] Microcirculation in hypertension - A new target for treatment?
    Levy, BI
    Ambrosio, G
    Pries, AR
    Struijker-Boudier, HAJ
    CIRCULATION, 2001, 104 (06) : 735 - 740
  • [22] Interventional Treatment of Hypertension: A New Paradigm
    W. Schuyler Jones
    Sreekanth Vemulapalli
    Manesh R. Patel
    Current Cardiology Reports, 2013, 15
  • [23] Update on Treatment of Hypertension After Renal Transplantation
    Christos Chatzikyrkou
    Roland E. Schmieder
    Mario Schiffer
    Current Hypertension Reports, 2021, 23
  • [24] The Role of Beta-Blockers in the Treatment of Hypertension
    Cruickshank, John M.
    HYPERTENSION: FROM BASIC RESEARCH TO CLINICAL PRACTICE, VOL 2, 2017, 956 : 149 - 166
  • [25] Update on Treatment of Hypertension After Renal Transplantation
    Chatzikyrkou, Christos
    Schmieder, Roland E.
    Schiffer, Mario
    CURRENT HYPERTENSION REPORTS, 2021, 23 (05)
  • [26] Hypertension in 2017: Update in Treatment and Pharmaceutical Innovations
    Okur, Mehmet Evren
    Karantas, Ioannis D.
    Okur, Neslihan Ustundag
    Siafaka, Panoraia I.
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (44) : 6795 - 6814
  • [27] Amlodipine treatment of hypertension associates with a decreased dementia risk
    Feldman, Leonid
    Vinker, Shlomo
    Efrati, Shai
    Beberashvili, Ilia
    Gorelik, Oleg
    Wasser, Walter
    Shani, Michal
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2016, 38 (06) : 545 - 549
  • [28] K+ and the renin-angiotensin-aldosterone system: new insights into their role in blood pressure control and hypertension treatment
    Poulsen, Soren B.
    Fenton, Robert A.
    JOURNAL OF PHYSIOLOGY-LONDON, 2019, 597 (17): : 4451 - 4464
  • [29] FELODIPINE AND ISRADIPINE - NEW CALCIUM-CHANNEL-BLOCKING AGENTS FOR THE TREATMENT OF HYPERTENSION
    WALTON, T
    SYMES, LR
    CLINICAL PHARMACY, 1993, 12 (04): : 261 - 275
  • [30] Cost-effectiveness of implementing new guidelines for treatment of hypertension in general practice
    Richardson, G
    Godfrey, L
    Gravelle, H
    Watt, I
    BRITISH JOURNAL OF GENERAL PRACTICE, 2004, 54 (507) : 765 - 771